In orthotopic mice models, exosomes derived from MSCs carrying short interfering RNA effectively suppressed tumor growth through targeting KRAS G12D, the most common mutation subtype in pancreatic cancer [112, 164]. This evidence concerns the gene KRAS and pancreatic neoplasm.